Although obesity may be associated with improved responses and survival rates in patients with NSCLC and other solid tumours treated with ICIs,155, 156 notably, a retrospective study on NSCLC patients receiving anti‐PD‐1/PD‐L1 therapy showed a positive correlation between increased body mass index (BMI) and irAEs risk.153. The gene discussed is CD274; the disease is non-small cell lung carcinoma.